Ranjita Sengupta

Ranjita Sengupta is a seasoned professional in Molecular Biology and Biochemistry with extensive experience in vector process development and production. Currently serving as Senior Director of Vector Process Development and CMC Lead for KYV-101 at Kyverna Therapeutics, Ranjita has previously held significant roles at Adicet Bio, Inc. and System Biosciences, where Ranjita managed production and quality control for a diverse product portfolio, including lentiviral and exosome products. Ranjita's career began at CV Therapeutics as a Senior Research Associate, contributing to discovery research related to cardiovascular diseases. Ranjita's educational background includes a Post Doctorate from the University of California, Berkeley, a PhD in Biochemistry from North Carolina State University, and a Bachelor of Science degree in Human Physiology with honors in Zoology and Chemistry.